Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Investigation of the Histopathologic Effect of Calcium Electroporation on Cancer in the Skin (CAEP-B)

NCT04259658 is registered in ClinicalTrials.gov with Zealand University Hospital as lead sponsor.

NCT NCT04259658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04259658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Investigation of the Histopathologic Effect of Calcium Electroporation on Cancer in the Skin (CAEP-B)
Lead sponsor
Zealand University Hospital
Phase
Phase 2
Overall status
Completed
Start date
April 20, 2020
Completion date
July 27, 2023
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer